Educational Impact on Apixaban Adherence in Atrial Fibrillation (the AEGEAN STUDY): A Randomized Clinical Trial

[1]  H. Heidbuchel,et al.  Telemonitoring-based feedback improves adherence to non-vitamin K antagonist oral anticoagulants intake in patients with atrial fibrillation , 2018, European heart journal.

[2]  A. Camm,et al.  The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation. , 2018, European heart journal.

[3]  N. Martell-Clarós,et al.  Strategies for improving dabigatran adherence for stroke prevention in patients with non-valvular atrial fibrillation: education and drug intake reminders (FACILITA study) , 2018, Current medical research and opinion.

[4]  Mircea Cinteza,et al.  A multifaceted intervention to improve treatment with oral anticoagulants in atrial fibrillation (IMPACT-AF): an international, cluster-randomised trial , 2017, The Lancet.

[5]  H. Diener.  Does atrial fibrillation lead to cognitive decline and dementia? , 2017, European heart journal.

[6]  G. Verleden,et al.  Efficacy of a medication adherence enhancing intervention in transplantation: The MAESTRO-Tx trial. , 2017, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[7]  Danielle E. Clarkesmith,et al.  Educational and behavioural interventions for anticoagulant therapy in patients with atrial fibrillation. , 2017, The Cochrane database of systematic reviews.

[8]  G. Lip,et al.  Adherence to oral anticoagulant therapy in patients with atrial fibrillation , 2016, Thrombosis and Haemostasis.

[9]  G. Breithardt,et al.  Choosing a particular oral anticoagulant and dose for stroke prevention in individual patients with non-valvular atrial fibrillation: part 2. , 2016, European heart journal.

[10]  G. Caleb Alexander,et al.  Effect of Adherence to Oral Anticoagulants on Risk of Stroke and Major Bleeding Among Patients With Atrial Fibrillation , 2016, Journal of the American Heart Association.

[11]  B. Gorenek,et al.  Cardiac tachyarrhythmias and patient values and preferences for their management: the European Heart Rhythm Association (EHRA) consensus document endorsed by the Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisi , 2015, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[12]  C. McHorney,et al.  Adherence to non-vitamin-K-antagonist oral anticoagulant medications based on the Pharmacy Quality Alliance measure , 2015, Current medical research and opinion.

[13]  M. Bouvy,et al.  Trends in antithrombotic drug use and adherence to non-vitamin K oral anticoagulants in the Netherlands , 2015, International Journal of Clinical Pharmacy.

[14]  M. Turakhia,et al.  Site-level variation in and practices associated with dabigatran adherence. , 2015, JAMA.

[15]  H. Heidbuchel,et al.  Non-vitamin K antagonist oral anticoagulants: considerations on once- vs. twice-daily regimens and their potential impact on medication adherence. , 2015, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[16]  G. Grunwald,et al.  Adherence to dabigatran therapy and longitudinal patient outcomes: insights from the veterans health administration. , 2014, American heart journal.

[17]  S. Kachroo,et al.  REAL WORLD DISCONTINUATION RATES WITH APIXABAN VERSUS WARFARIN, DABIGATRAN, OR RIVAROXABAN AMONG ATRIAL FIBRILLATION PATIENTS NEWLY INITIATED ON ANTICOAGULATION THERAPY: EARLY FINDINGS , 2014 .

[18]  E. Antman,et al.  Edoxaban versus warfarin in patients with atrial fibrillation. , 2013, The New England journal of medicine.

[19]  P. Wells,et al.  Non‐adherence to new oral anticoagulants: a reason for concern during long‐term anticoagulation? , 2013, Journal of thrombosis and haemostasis : JTH.

[20]  F. Dobbels,et al.  Improved Adherence to Tacrolimus Once-Daily Formulation in Renal Recipients: A Randomized Controlled Trial Using Electronic Monitoring , 2013, Transplantation.

[21]  Jeffrey K Aronson,et al.  A new taxonomy for describing and defining adherence to medications. , 2012, British journal of clinical pharmacology.

[22]  P. Aslani,et al.  Interventions promoting adherence to cardiovascular medicines , 2012, International Journal of Clinical Pharmacy.

[23]  D. Atar,et al.  Apixaban versus warfarin in patients with atrial fibrillation. , 2011, The New England journal of medicine.

[24]  G. Breithardt,et al.  Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. , 2011, The New England journal of medicine.

[25]  S. Yusuf,et al.  Newly identified events in the RE-LY trial. , 2010, The New England journal of medicine.

[26]  M. Fang,et al.  Current issues in patient adherence and persistence: focus on anticoagulants for the treatment and prevention of thromboembolism , 2010, Patient preference and adherence.

[27]  Sofie Vandenbroeck,et al.  How Accurate Are Electronic Monitoring Devices? A Laboratory Study Testing Two Devices to Measure Medication Adherence , 2010, Sensors.

[28]  Krzysztof Narkiewicz,et al.  The impact of an electronic monitoring and reminder device on patient compliance with antihypertensive therapy: a randomized controlled trial , 2010, Journal of hypertension.

[29]  S. Yusuf,et al.  Dabigatran versus warfarin in patients with atrial fibrillation. , 2009, The New England journal of medicine.

[30]  Tiny Jaarsma,et al.  Adherence in heart failure in the elderly: problem and possible solutions. , 2008, International journal of cardiology.

[31]  Jia-Rong Wu,et al.  Medication adherence in patients who have heart failure: a review of the literature. , 2008, The Nursing clinics of North America.

[32]  M. Aguilar,et al.  Meta-analysis: Antithrombotic Therapy to Prevent Stroke in Patients Who Have Nonvalvular Atrial Fibrillation , 2007, Annals of Internal Medicine.

[33]  L. Osterberg,et al.  Adherence to medication. , 2005, The New England journal of medicine.

[34]  F. Kamali,et al.  The value of education and self‐monitoring in the management of warfarin therapy in older patients with unstable control of anticoagulation , 2004, British journal of haematology.

[35]  R. Lilford,et al.  Are randomized clinical trials good for us (in the short term)? Evidence for a "trial effect". , 2001, Journal of clinical epidemiology.

[36]  A. Cohen-Solal,et al.  An education program for risk factor management after an acute coronary syndrome: a randomized clinical trial. , 2014, JAMA internal medicine.

[37]  Ann Partridge,et al.  Patient adherence and persistence with oral anticancer treatment , 2009, CA: a cancer journal for clinicians.